Clinical Trial Update: Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral topotecan (HYCAMTIN) in combination with whole-brain radiation therapy for brain metastases from non-small cell lung cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Hycamtin (Topotecan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 3 | Status: COMPLETED | Results posted: 2014-01-20